FDA Import Refusal SCS-2375836-2/11/1 — Allergan Inc
The FDA refused shipment SCS-2375836-2/11/1 from Allergan Inc (Canada) on Oct 30, 2020. The refused product falls under Drugs and Biologics — BOTOX. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 30, 2020
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 65QAY02 BOTOX
- Charges
- 75